Leaders | American drugs policy

Psychedelic therapy shows great promise. More states should legalise it

Oregon’s trailblazing sets a fine example

PICTURE YOURSELF in a boat on a river, with tangerine trees, marmalade skies—and licensed professionals who may finally be able to help you overcome your treatment-resistant depression. The first half of that sentence reflects the Beatles-era view of psychedelic drugs. The second is a new policy being pioneered in Oregon, which could herald a welcome shift in America more broadly.

This article appeared in the Leaders section of the print edition under the headline “Oregon’s trailblazing”

Russia’s roulette: The stakes in Ukraine

From the January 29th 2022 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Leaders

Keir Starmer surrounded by the Eu stars

Sir Keir Starmer should aim higher in his reset with the EU

And he needs to be clearer about what Britain wants

illustration of a world map outlined by a single red electrical cord, with a plug at one end and a socket at the other

To make electricity cheaper and greener, connect the world’s grids

Less than 3% of the world’s power is internationally traded—a huge wasted opportunity


Chinese AI is catching up, posing a dilemma for Donald Trump

The success of cheap Chinese models threatens America’s technological lead


America has an imperial presidency

And in Donald Trump, an imperialist president for the first time in over a century

Tariffs will harm America, not induce a manufacturing rebirth

Donald Trump’s pursuit of tariffs will make the world poorer—and America, too 

How to improve clinical trials

Involving more participants can lead to new medical insights